The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s naloxone spray market report forecasts the naloxone spray market size to grow to $1.2 Billion by 2027, with a CAGR (compound annual growth rate) of more than 23%.

Learn More On The Naloxone Spray Market Report 2023 – https://www.thebusinessresearchcompany.com/report/naloxone-spray-global-market-report

Naloxone Spray Market Size Forecast
The global naloxone spray market is expected to grow from $0.4 billion in 2022 to $0.53 billion in 2023 at a compound annual growth rate (CAGR) of 22.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The naloxone spray market size is expected to grow to $1.2 billion in 2027 at a CAGR of 23.1%.

North America held the largest naloxone spray market share.

Key Naloxone Spray Market Driver ­– Increase In The Prevalence Of Opioid Overdoses
According to data released by the Centers for Disease Control and Prevention, opioids were responsible for 49,860 overdose deaths in February 2021, accounting for 70.6% of all drug overdose deaths (CDC). According to the WHO, opioids will be responsible for more than 70% of fatalities by 2020, with overdose accounting for 30% of these deaths. Naloxone nasal spray is used in emergency medicine to reverse the potentially fatal effects of an opiate or opioid overdose. As opioid overdoses become more common, the market for naloxone spray is growing.

Request for A Sample Of The Global Naloxone Spray Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5339&type=smp

Key Naloxone Spray Market Trend – Increasing Product Approvals
Large naloxone spray manufacturers are focusing on new product approvals in order to diversify their product lines and expand their naloxone spray business. For example, Hikma Pharmaceuticals’ KLOXXADOTM (naloxone hydrochloride) nasal spray 8mg was approved by the US Food and Drug Administration (FDA) in April 2021 for the immediate treatment of recognized or suspected opioid overdose in both adult and paediatric patients, as evidenced by respiratory and/or central nervous system depression. KLOXXADOTM provides a significant new treatment to combat the opioid epidemic, containing twice as much naloxone per spray as Narcan Nasal Spray 4mg in a ready-to-use nasal spray to reverse the effects of opioid overdose.

Naloxone Spray Market Segment
1) By Dosage: 2 mg/Actuation, 4 mg/Actuation
2) By Distribution Channel: Hospitals, Clinics, Retail Pharmacies, Online Pharmacies, Other distribution channels

Naloxone Spray Market Major Players and Strategies
Major players in the naloxone spray market are Emergent BioSolutions, Pfizer, Teva Pharmaceutical Industries Ltd., Opiant Pharmaceuticals, Hikma Pharmaceuticals, Nasus Pharma, Amphastar Pharmaceuticals, Indivior PLC, Samarth Pharma Pvt. Ltd., Troikaa Pharmaceuticals Ltd., and Neon Laboratories Limited.

Aptar Pharma, based in the United States, and DNE Pharma, based in Norway, announced a collaboration in March 2021 to develop drugs to treat addiction. Through this collaboration, both companies are providing training programs and their expertise in nasal drug delivery to treat an opioid overdose using Ford Pharma’s Ventizolve® nasal naloxone in an effort to improve patient access and combat the opioid epidemic.

The Naloxone Spray Global Market Report 2023 covers regional data on naloxone spray market size, naloxone spray market trends and drivers, opportunities, strategies, and naloxone spray market competitor analysis. The countries covered in the naloxone spray market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Naloxone spray is a chemical that binds to opioid receptors to prevent or reverse the effects of other opioids. Administering naloxone immediately reverses the effects of opioid drugs, restoring normal breathing. There are two options for administration: intravenous and nasal spray. Each naloxone nasal spray contains a single dose of the drug and should only be used once. Naloxone is available as a nasal spray solution (liquid).

View More Reports Related To The Naloxone Spray Market –
Spray Drying Equipment Global Market Report 2023
Antidepressants Global Market Report 2023
Neurostimulation Devices Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: